Salvalaggio, Alessandro http://orcid.org/0000-0002-1273-7566
Coraci, Daniele
Cacciavillani, Mario
Obici, Laura
Mazzeo, Anna
Luigetti, Marco
Pastorelli, Francesca
Grandis, Marina
Cavallaro, Tiziana
Bisogni, Giulia
Lozza, Alessandro
Gemelli, Chiara
Gentile, Luca
Ermani, Mario
Fabrizi, Gian Maria
Plasmati, Rosaria
Campagnolo, Marta
Castellani, Francesca
Gasparotti, Roberto
Martinoli, Carlo
Padua, Luca
Briani, Chiara
Funding for this research was provided by:
Pfizer Inc
Article History
Received: 13 April 2020
Revised: 27 July 2020
Accepted: 28 July 2020
First Online: 4 August 2020
Compliance with ethical standards
:
: Alessandro Salvalaggio reports travel grants from Alnylam, Akcea and Pfizer. Laura Obici reports speaker and consulting honoraria from Akcea, Alnylam and Pfizer. Marco Luigetti reports financial grants (honoraria and speaking) from Akcea, Alnylam and Pfizer, and travel grants from Pfizer, Kedrion and Grifols. Gulia Bisogni reports financial grants (honoraria and speaking) from Alnylam and travel grants from Pfizer and Grifols. Gian Maria Fabrizi reports consulting honoraria from Akcea and Alnylam, and travel grants from Kedrion and Alnylam. Marta Campagnolo reports travel grants from Alnylam and Akcea. Francesca Castellani reports travel grants from Alnylam. Carlo Martinoli reports financial relationships (consultant, speaker fees, adv board) with Pfizer, Novartis, Sobi, Takeda e Novonordisk. Chiara Briani reports speaker and consulting honoraria from Akcea, Alnylam and Pfizer, and travel grants from Kedrion, Alnylam and CSL Behring.
: The study was approved by the <i>“Comitato Etico per la Sperimentazione Clinica della Provincia di Padova”</i> and by local ethical committees of all the involved centers.
: Enrolled subjects gave written informed consent to participate to the study.
: All the Authors have read and approved the manuscript for publication.